Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ebastine in Irritable Bowel Syndrome
NCT01144832Phase 4Completed
- Sponsor
- KU Leuven
- Start
- Oct 2009
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in irritable bowel syndrome (IBS) comparing Ebastine with Placebo (2 arms). Primary endpoint: Effect of treatment on visceral sensitivity measured with rectal barostat at 12 weeks. Started Oct 2009; status: completed.
02
Drugs
eribulin
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT01144832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01144832.